MISSLING CHRISTOPHER U 4
4 · ANAVEX LIFE SCIENCES CORP. · Filed Aug 22, 2025
Insider Transaction Report
Form 4
MISSLING CHRISTOPHER U
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-08-20+125,000→ 125,000 totalExercise: $8.58From: 2025-08-20Exp: 2035-03-31→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]On March 31, 2025, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was Publication of preclinical blarcamesine prevention AD data. The performance criteria for this milestone was met, resulting in vesting of the option as to 125,000 shares.